Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Empagliflozin for Neutropenia in Glycogenosis Ib
NCT04930627Phase 2Unknown
- Sponsor
- Children's Memorial Health Institute
- Start
- Jul 2021
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of empagliflozin in glycogen storage disease type 1b, sponsored by Children's Memorial Health Institute. Status: unknown.
02
Drugs
empagliflozin
03
Conditions
glycogen storage disease type 1b
Beyond the preview
Go deeper on NCT04930627.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04930627.